Following his recent induction into the Canadian Medical Hall of Fame—and at the end of his term as Canadian Neurological ...
Brainomix and Remedy Pharmaceuticals have announced “promising new findings” from a post-hoc analysis of the Phase 3 CHARM ...
Pharaoh Neuro has announced that the US Food and Drug Administration has granted Breakthrough Device designation to its ...
As the topic of radiation safety across various interventional specialties continues to garner increased interest, Melissa ...
The UK government has confirmed that it will continue to accept CE marked medical devices on a long-term basis, meaning ...
In light of their position paper on ‘stroke prevention in the longevity era’ published recently in Stroke, Gustavo Saposnik (Toronto, Canada) and Conrado E... Following his recent induction into the ...
On World Stroke Day 2026 (29 October), the European Society of Minimally Invasive Neurological Therapy (ESMINT) has called for sustained investment in education, research, and stroke services.
Resolve Therapeutics has announced two e-posters featuring preclinical data on its RNase-Fc fusion protein RSLV-132, and its ...
Abbott has announced that the US Food and Drug Administration (FDA) has approved its new Proclaim Plus spinal cord stimulation (SCS) system featuring FlexBurst360 therapy. The company describes ...
Post-hoc analyses of a large, randomised clinical trial have revealed the potential advantages associated with electronic informed consent (eConsent) in acute ischaemic stroke studies, including ...
Vital3D Technologies—a Lithuanian deep-tech company developing precision 3D microfabrication technology for medical devices, therapeutics and regenerative medicine—today announced a ‘know-how licence ...
Remedy Robotics has debuted what it claims is the “world’s first” remotely operable endovascular robotic platform: the Remedy N1 system. A press release from the company notes that, by combining ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results